1. Home
  2. NWTG vs LABT Comparison

NWTG vs LABT Comparison

Compare NWTG & LABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc.

NWTG

Newton Golf Company Inc.

N/A

Current Price

$1.11

Market Cap

6.2M

ML Signal

N/A

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$0.93

Market Cap

5.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWTG
LABT
Founded
2018
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.3M
IPO Year
2022
2026

Fundamental Metrics

Financial Performance
Metric
NWTG
LABT
Price
$1.11
$0.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.8K
★ 611.3K
Earning Date
11-12-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 99.09
N/A
EPS
★ N/A
N/A
Revenue
★ $8,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$104.02
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 136.14
N/A
52 Week Low
$0.70
$0.92
52 Week High
$1.97
$6.85

Technical Indicators

Market Signals
Indicator
NWTG
LABT
Relative Strength Index (RSI) N/A 27.99
Support Level N/A N/A
Resistance Level N/A $2.50
Average True Range (ATR) 0.00 0.23
MACD 0.00 -0.11
Stochastic Oscillator 0.00 2.21

Price Performance

Historical Comparison
NWTG
LABT

About NWTG Newton Golf Company Inc.

Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Share on Social Networks: